Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glykad G 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Salveo Lifecare

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glykad G 2mg/500mg Tablet SR

Diabetic patients with type 2 mellitus may benefit from the dual-action antidiabetic medication, Glykad G 2mg/500mg SR tablets. This formulation combines two active agents to effectively manage blood glucose levels in adults. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage adjustments will be determined by your physician based on your individual response and blood glucose monitoring. Continuous use is crucial, even with well-controlled blood sugar; abrupt cessation can lead to dangerous hyperglycemia and potential complications such as renal impairment, vision loss, neuropathy, and limb ischemia. Remember, Glykad G is just one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications are paramount in diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, manifesting as sweating, lightheadedness, cephalgia, and tremors. Prompt recognition and treatment with readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Glykad G is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Individuals with a history of cardiovascular disease should inform their doctor before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess hematological and hepatic function) will be conducted under your doctor's supervision.

Uses of Glykad G 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glykad G 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glykad G 2mg/500mg sustained-release tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glykad G 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glykad G 2mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glykad G 2mg/500mg Sustained-Release tablets with food.

How Glykad G 2mg/500mg Tablet SR works:

Glykad G 2mg/500mg sustained-release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and Glykad G 2mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glykad G 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glykad G 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glykad G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glykad G 2mg/500mg SR tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glykad G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, Glykad G 2mg/500mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glykad G 2mg/500mg Tablet SR :

Should you forget a Glykad G 2mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glykad G 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glykad G 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glykad G 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glykad G 2mg/500mg Tablet SR and seek immediate medical attention.
Glykad G 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glykad G 2mg/500mg SR Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glykad G 2mg/500mg Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Glykad G 2mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glykad G 2mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glykad G 2mg/500mg Tablet...
62
MRP 75
17% off